BMC VMF Group

Jennifer Quizi, PhD

613-737-8899 x75201
jquizi@ohri.ca

News

ScaleReady grant to fuel development of innovative cancer treatments at The Ottawa Hospital’s Biotherapeutics Manufacturing Centre November 25, 2025 - ScaleReadyTM, in collaboration with Wilson Wolf Manufacturing, Bio-Techne Corporation and CellReadyTM, announced today that the Biotherapeutics Manufacturing Centre (BMC) at The Ottawa Hospital’s Research Institute (OHRI) has been awarded a ...
Researchers at The Ottawa Hospital awarded $3.9M from BioCanRx to develop new cancer immunotherapies April 9, 2025 - Researchers at The Ottawa Hospital have been awarded $3.9 million from BioCanRx to develop cutting-edge biotherapeutics that harness the immune system to fight cancer.
Bringing cellular immunotherapy to solid tumours: made-in-Canada approach to be pioneered in biliary tract cancers thanks to $7.4M grant April 13, 2023 - Canadians with biliary tract cancer (cholangiocarcinoma and gallbladder) will have the first chance to benefit from a new made-in-Canada approach to personalized cellular immunotherapy, thanks to a $7.4 million grant from the Canadian Cancer ...